
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.070 | 1.070 | 0.000 |
Shares | 98.930 | 98.930 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.976 | 15.891 |
Price to Book | 3.711 | 3.768 |
Price to Sales | 5.484 | 5.106 |
Price to Cash Flow | 17.809 | 14.694 |
Dividend Yield | 0.152 | 0.523 |
5 Years Earnings Growth | 3.448 | 6.307 |
Number of long holdings: 54
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Argen-X | NL0010832176 | 6.28 | 568.40 | -1.29% | |
Verona Pharma ADR | US9250501064 | 4.72 | 105.280 | -0.11% | |
Ascendis Pharma AS | US04351P1012 | 4.67 | 191.49 | +0.60% | |
Rhythm Pharma | US76243J1051 | 4.50 | 91.98 | -0.54% | |
Alnylam | US02043Q1076 | 4.41 | 438.93 | +0.88% | |
Arcutis | US03969K1088 | 3.99 | 14.77 | +4.60% | |
Insmed | US4576693075 | 3.99 | 109.55 | +0.23% | |
Soleno Therapeutics | US8342033094 | 3.90 | 82.3500 | +4.62% | |
Madrigal Pharma | US5588681057 | 3.88 | 345.73 | +1.00% | |
UCB | BE0003739530 | 3.63 | 184.50 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund I E | 8.48B | 25.79 | 28.69 | 20.30 | ||
Global Technology Fund RE | 8.48B | 25.42 | 28.04 | 19.78 | ||
Global Technology FunD E | 8.48B | 17.39 | 29.43 | 19.08 | ||
IE00BZ4D7648 | 8.48B | 2.04 | 16.56 | - | ||
IE00BZ4D7085 | 8.48B | 2.23 | 17.11 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review